Effectiveness of sitagliptin in Cystic Fibrosis with impaired glucose tolerance
Brief Description Of Study
This study will evaluate how effective sitagliptin, a DPP-IV inhibitor, is at improving glycemic control in the Cystic Fibrosis population.
Detailed Study Description
This trial will evaluate the participant's metabolic response pre- and post-treatment using a Mixed Meal Tolerance Test and a Glucose Potentiated Arginine Test.
Additional Information About The Study
The above is a very brief overview. ' Please contact the Research Coordinator for further questions at email@example.com or call 215-746-2081